ROBO1 and neoplasm: Despite the initial tumor size being similar, xenografts bearing miR-588-U87MG cells exhibited tumor growth inhibition and longer survival times than control group, whereas overexpression of ROBO1 inhibited the effect of miR-588 in vivo (Figure S3C, D).